X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (27) 27
humans (25) 25
animals (16) 16
cancer (16) 16
female (16) 16
mice (15) 15
oncology (15) 15
ovarian cancer (10) 10
article (9) 9
cell line, tumor (9) 9
tumors (9) 9
carcinoma (8) 8
cells (8) 8
middle aged (8) 8
mutation (8) 8
chemotherapy (7) 7
expression (7) 7
gene expression (7) 7
aged (6) 6
genetic aspects (6) 6
obstetrics & gynecology (6) 6
xenografts (6) 6
adult (5) 5
diagnosis (5) 5
ovarian neoplasms - genetics (5) 5
ovarian neoplasms - pathology (5) 5
trastuzumab (5) 5
xenograft model antitumor assays (5) 5
analysis (4) 4
biology (4) 4
cells, cultured (4) 4
growth (4) 4
her2 (4) 4
immunology (4) 4
inhibitors (4) 4
interferon (4) 4
male (4) 4
medical research (4) 4
mice, knockout (4) 4
multidisciplinary sciences (4) 4
ovarian neoplasms - drug therapy (4) 4
phase-ii trial (4) 4
pik3ca (4) 4
therapy (4) 4
abridged index medicus (3) 3
activation (3) 3
antineoplastic agents - pharmacology (3) 3
autoimmune cholangitis (3) 3
binding (3) 3
biochemistry (3) 3
biocompatibility (3) 3
biotechnology (3) 3
breast-cancer (3) 3
cell biology (3) 3
cell survival - drug effects (3) 3
cell survival - genetics (3) 3
cytotoxicity (3) 3
dna sequencing (3) 3
endocrinology & metabolism (3) 3
endometrial cancer (3) 3
gene expression profiling (3) 3
gene expression regulation (3) 3
genes (3) 3
health aspects (3) 3
hematology (3) 3
her2/neu (3) 3
mathematical & computational biology (3) 3
maytansine - analogs & derivatives (3) 3
metastases (3) 3
metastasis (3) 3
mutation - genetics (3) 3
mutations (3) 3
neoplasms - metabolism (3) 3
ovarian carcinoma (3) 3
ovarian neoplasms - metabolism (3) 3
patients (3) 3
proteins (3) 3
pulmonary fibrosis (3) 3
receptor, erbb-2 - genetics (3) 3
rna, messenger - genetics (3) 3
signal transduction (3) 3
t-dm1 (3) 3
toxicity (3) 3
tumor cell lines (3) 3
tumor cells (3) 3
uterine neoplasms - genetics (3) 3
uterine serous carcinoma (3) 3
xenotransplantation (3) 3
acquired-resistance (2) 2
aged, 80 and over (2) 2
alternative activation (2) 2
angiogenesis (2) 2
antibody-drug conjugate (2) 2
anticancer properties (2) 2
antitumor activity (2) 2
artificial intelligence (2) 2
biochemical research methods (2) 2
biochemistry & molecular biology (2) 2
biological sciences (2) 2
biomarkers, tumor - biosynthesis (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cytokine and Growth Factor Reviews, ISSN 1359-6101, 2009, Volume 21, Issue 1, pp. 27 - 39
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 10/2016, Volume 113, Issue 43, pp. 12238 - 12243
Journal Article
ISSN 2040-3364, 8/2019, Volume 11, Issue 3, pp. 1423 - 1429
Herein, supramolecular carbon nanoparticle aggregates were obtained via covalent functionalization of the shell of nanoparticles with triazine and subsequent... 
Journal Article
Nanoscale, ISSN 2040-3364, 01/2019, Volume 11, Issue 30, pp. 14203 - 14209
Herein, supramolecular carbon nanoparticle aggregates were obtained via covalent functionalization of the shell of nanoparticles with triazine and subsequent... 
Nanoparticles | Organic chemistry | Self assembly | Naphthalene | Optical properties | Information transfer | Diffusion coefficient | Carbon | Hydrogen bonding | Diimide | Optimization | Communication
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 10/2017, Volume 23, Issue 19, pp. 5836 - 5845
Purpose: Carcinosarcomas (CS) are highly aggressive gynecologic malignancies containing both carcinomatous and sarcomatous elements with heterogeneous HER2/neu... 
EPITHELIAL-MESENCHYMAL TRANSITION | TRASTUZUMAB PLUS DOCETAXEL | PHASE-II TRIAL | GYNECOLOGIC-ONCOLOGY-GROUP | ONCOLOGY | GASTRIC-CANCER | SEROUS CARCINOMA | METASTATIC BREAST-CANCER | ENDOMETRIAL CARCINOSARCOMA | PRECLINICAL PROFILE | MONOCLONAL-ANTIBODY | Receptor, ErbB-2 - genetics | Uterine Neoplasms - pathology | Humans | Ovarian Neoplasms - pathology | Antibody-Dependent Cell Cytotoxicity - immunology | Pyrrolidinones - immunology | Immunoconjugates - administration & dosage | Indoles - administration & dosage | Carcinosarcoma - immunology | Immunoconjugates - immunology | Ovarian Neoplasms - genetics | Pyrrolidinones - administration & dosage | Female | Receptor, ErbB-2 - antagonists & inhibitors | Receptor, ErbB-2 - immunology | Gene Expression Regulation, Neoplastic - drug effects | Ovarian Neoplasms - drug therapy | Carcinosarcoma - pathology | Uterine Neoplasms - genetics | Maytansine - analogs & derivatives | Indoles - immunology | Trastuzumab - administration & dosage | Xenograft Model Antitumor Assays | Maytansine - administration & dosage | Animals | Uterine Neoplasms - drug therapy | Cell Line, Tumor | Carcinosarcoma - drug therapy | Carcinosarcoma - genetics | Cell Proliferation - drug effects | Mice | Trastuzumab - immunology | Maytansine - immunology | Uterine Neoplasms - immunology | Ovarian Neoplasms - immunology | Biotechnology | Animal models | Toxicity | Tumor cells | Effector cells | Cytotoxicity | Gene expression | ErbB-2 protein | Anticancer properties | Gene amplification | Chemotherapy | Uterus | Experimental design | Cell lines | Xenografts | Antitumor activity | Biocompatibility | In vivo methods and tests | Viability | Trastuzumab | Cancer | SYD985 | T-DM1 | HER2 | Uterine Carcinosarcoma | Ovarian Carcinosarcoma
Journal Article
Blood, ISSN 0006-4971, 01/2012, Volume 119, Issue 2, pp. 411 - 421
Journal Article
Journal Article
Diabetes Technology & Therapeutics, ISSN 1520-9156, 03/2019, Volume 21, Issue 3, pp. 146 - 153
Objective: To develop and validate a new risk score for intraventricular hemorrhage (IVH) in preterm neonates based on continuous glucose monitoring (CGM).... 
Original Articles | TIGHT GLYCEMIC CONTROL | OXYGENATION | Very low-birth-weight infants | SENSOR | NEURODEVELOPMENTAL OUTCOMES | Brain hemorrhage | AUTOREGULATION | CARE | Continuous glucose monitoring | VARIABILITY | HYPERGLYCEMIA | Preterm infants | INFANTS | ENDOCRINOLOGY & METABOLISM | HYPOGLYCEMIA | Very preterm infants | IVH
Journal Article
NANOSCALE, ISSN 2040-3364, 08/2019, Volume 11, Issue 30, pp. 14203 - 14209
Herein, supramolecular carbon nanoparticle aggregates were obtained via covalent functionalization of the shell of nanoparticles with triazine and subsequent... 
PHYSICS, APPLIED | MOLECULAR COMMUNICATION | MATERIALS SCIENCE, MULTIDISCIPLINARY | SUPRAMOLECULAR INTERACTIONS | NANOSCIENCE & NANOTECHNOLOGY | NANODOTS | CHEMISTRY, MULTIDISCIPLINARY | QUANTUM DOTS
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 01/2019, Volume 116, Issue 2, pp. 619 - 624
Ovarian cancer remains the most lethal gynecologic malignancy. We analyzed the mutational landscape of 64 primary, 41 metastatic, and 17 recurrent fresh-frozen... 
Ovarian carcinoma | Whole-exome sequencing | BET inhibitors | Bilateral ovarian tumors | PIK3CA | COPY-NUMBER | MULTIDISCIPLINARY SCIENCES | ovarian carcinoma | whole-exome sequencing | bilateral ovarian tumors | Class I Phosphatidylinositol 3-Kinases - genetics | Class I Phosphatidylinositol 3-Kinases - metabolism | Humans | Neoplasm Recurrence, Local - drug therapy | Tumor Suppressor Protein p53 - genetics | Neoplasm Metastasis | BRCA1 Protein - metabolism | Female | Antineoplastic Agents - pharmacology | Ovarian Neoplasms | Neoplasm Recurrence, Local - metabolism | Tumor Suppressor Protein p53 - metabolism | Proto-Oncogene Proteins c-myc - metabolism | Azepines - pharmacology | Proteins - genetics | Triazoles - pharmacology | Xenograft Model Antitumor Assays | BRCA1 Protein - genetics | Animals | BRCA2 Protein - metabolism | Proteins - metabolism | Cell Line, Tumor | Neoplasm Recurrence, Local - genetics | Mice | Proto-Oncogene Proteins c-myc - genetics | Mutation | Proteins - antagonists & inhibitors | BRCA2 Protein - genetics | Relapse | Genetic aspects | Metastasis | Health aspects | Mutation (Biology) | Ovarian cancer | Cancer | p53 Protein | Genes | Xenotransplantation | c-Myc protein | Malignancy | Myc protein | Metastases | Gene sequencing | Xenografts | Evolution | Deoxyribonucleic acid--DNA | Nucleotide sequence | BRCA1 protein | Therapeutic applications | Gynecology | Breast cancer | Patients | Amplification | Chemotherapy | Inhibitors | Cell lines | Gain | DNA sequencing | Tumors | Biological Sciences
Journal Article